Fig. 1 · Structure

Documents & Downloads

Legubicin

Anti-cancer Agent

Legubicin is a targeted anti-cancer agent comprising doxorubicin linked to a Legumain-cleavable peptide. This compound is selectively activated by Legumain, allowing for the release of leucine-doxorubicin while minimizing effects on normal tissues. Legubicin effectively inhibits tumor cell proliferation and decreases DNA binding in cells that do not express Legumain. In preclinical models, Legubicin has demonstrated complete tumor growth arrest in mice with CT26 tumors, making it a valuable tool for investigating colon carcinoma (CRC).

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 606967-53-7
Applications Anti-cancer Agent
Formula C48H64N6O18
Molecular Weight 1013.05
Synonyms Doxorubicin-LNAA-Boc
SMILES
OC1=C2C(C(C3=C(OC)C=CC=C3C2=O)=O)=C(O)C([C@H]4O[C@@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC([C@H](CC(C)C)NC([C@H](CC(N)=O)NC([C@H](C)NC([C@H](C)NC(OC(C)(C)C)=O)=O)=O)=O)=O)=C1C[C@](O)(C4)C(CO)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...